首页> 外文期刊>Antimicrobial Resistance and Infection Control >Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland
【24h】

Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland

机译:波兰华沙三所教学医院住院患者分离的耐糖肽金黄色葡萄球菌菌株的特征

获取原文
           

摘要

Vancomycin is still one of the most commonly used drug for treatment of severe methicillin-resistant Staphylococcus aureus (MRSA) infections. Vancomycin-resistant S. aureus (VRSA) strains are a serious danger for public health. This study aimed to characterize healthcare-associated MRSA (HA-MRSA) strains, resistant to at least one of glycopeptide antibiotics: vancomycin (VRSA) and/or teicoplanin (TRSA), isolated at three Warsaw hospitals over a period of 17-years (1991–2007). Among 600 HA-MRSA strains, isolated from patients with symptomatic infections, 47 were subjected to detailed analysis. In the study, mechanisms behind VRSA phenotypes were determined (E-tests, GRD-test, agar-dilution method and vanA/B detection). Characteristics of selected isolates on molecular level: i) by detection of resistance genes ermA/ermB/ermC, msrA/msrB, linA/linA’, aacA-aphD, aadD, aph(3”)-IIIa; ii) SCCmec-typing and iii) MLST-typing was done. In general population of studied strains, 11/47 (23.4%) were VRSA and 36/47 (76.6%) were resistant only to teicoplanin. All isolates exhibited van-independent mechanisms of resistance. Over 80% of isolates belonged to clonal complex CC8, with the following predominant sequence types (STs)/clones: ST247-IA/Iberian, ST241-III/Finland-UK, and ST239-III/Brazilian. Most of the isolated strains harboured ermA and aacA-aphD genes, encoding additional resistance to macrolides, lincosamides, streptogramin B, and majority of aminoglycosides. They occurred also in Polish VRSA/TRSA population over the period, which was subjected for analysis: an increase in MIC values for glycopeptides, evolution in terms of the level and extent of resistance, and genetic re-assortment in epidemic clones. VRSA strains isolated from patients hospitalized at three Warsaw teaching hospitals in Poland, over a period of 17-years do not pose a threat as potential donors of van genes in horizontal-gene transfer processes, but are constantly evolving and represent international epidemic clones.
机译:万古霉素仍然是治疗严重耐甲氧西林金黄色葡萄球菌(MRSA)感染的最常用药物之一。耐万古霉素的金黄色葡萄球菌(VRSA)菌株严重危害公共健康。这项研究旨在表征在17年的时间里从三所华沙医院分离出的对至少一种糖肽抗生素万古霉素(VRSA)和/或替考拉宁(TRSA)耐药的医疗相关MRSA(HA-MRSA)菌株的特征( 1991–2007)。从有症状感染患者中分离出的600株HA-MRSA菌株中,有47例进行了详细分析。在这项研究中,确定了VRSA表型背后的机制(E检验,GRD检验,琼脂稀释法和vanA / B检测)。所选分离物在分子水平上的特征:i)通过检测抗性基因ermA / ermB / ermC,msrA / msrB,linA / linA’,aacA-aphD,aadD,aph(3”)-IIIa。 ii)完成了SCCmec分型和iii)MLST分型。在研究菌株的总种群中,VRSA占11/47(23.4%),仅对替考拉宁耐药(36/47)(76.6%)。所有分离株均表现出与van无关的抗性机制。超过80%的分离物属于克隆复合物CC8,具有以下主要序列类型(ST)/克隆:ST247-IA / Iberian,ST241-III / Finland-UK和ST239-III / Brazilian。大多数分离出的菌株带有ermA和aacA-aphD基因,编码对大环内酯类,林可酰胺,链霉菌素B和大多数氨基糖苷类的额外抗性。在此期间,它们也发生在波兰的VRSA / TRSA人群中,需要进行分析:糖肽的MIC值增加,耐药水平和程度的演变以及流行性克隆中的基因重排。从波兰三所华沙教学医院住院的患者中分离出的VRSA病毒株在长达17年的时间里并未作为水平基因转移过程中van基因的潜在供体而构成威胁,但仍在不断发展并代表国际流行病克隆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号